Efficacy, tolerability and safety of Valsartan in patients with mild to moderate essential hypertension at the University of Nigeria teaching hospital, Enugu

@inproceedings{Onwubere2007EfficacyTA,
  title={Efficacy, tolerability and safety of Valsartan in patients with mild to moderate essential hypertension at the University of Nigeria teaching hospital, Enugu},
  author={Bjc Onwubere and Chinwuba K. Ijoma and Bc Anisiuba},
  year={2007}
}
An open label, optional titration trial to evaluate the efficacy, tolerability and safety of Valsartan 80mg o.d/Valsartan 160mg o.d. in patients with mild to moderate hypertension treated for eight weeks. Twenty consenting subjects (11 males and 9 females) aged 29 to 79 years (mean age 48. 2 ± 11. 9yrs) were treated for eight weeks with Valsartan. Ten of the 20 subjects (50%) had diastolic blood pressure (DBP) end point below 90mmhg while 4 had a DBP end point of 90mmHg. There was significant… CONTINUE READING

Topics from this paper.